Desensitization and sensitization of cells to fluoropyrimidines with different antisenses directed against thymidylate synthase messenger RNA

Clinical Cancer Research

Volumn 4, Issue 9, 1998, Pages 2229-2236

  Ju, Jingfang ^a   Kane, Susan E ^b   Lenz, Heinz Josef ^a   Danenberg, Kathleen D ^a   Chu, Edward ^c   Danenberg, Peter V ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROPYRIMIDINE; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE; THYMIDYLATE SYNTHASE;

ARTICLE; CELL CULTURE; CHEMOSENSITIVITY; CYTOTOXICITY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA TRANSLATION;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; DRUG INTERACTIONS; DRUG SCREENING ASSAYS, ANTITUMOR; FLOXURIDINE; HT29 CELLS; HUMANS; KB CELLS; OLIGORIBONUCLEOTIDES, ANTISENSE; PLASMIDS; RABBITS; RNA, MESSENGER; THYMIDYLATE SYNTHASE; TRANSFECTION;

EID: 0031720067     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Danenberg, P. V. Thymidylate synthase: a target enzyme in cancer chemotherapy. Biochem. Biophys. Acta, 473: 73-79, 1977.
2. Moertel, C. G. Chemotherapy for colorectal cancer. N. Engl. J. Med., 330: 1136-1143, 1994.
3. Grem, J. L. 5-Fluorouracil plus leucovorin in cancer therapy. In: V. T. De Vita, Jr., S. Hellman, and S. A. Rosenberg (eds.), Principles and Practice of Oncology Update Series, Vol. 2. Philadelphia: J. B. Lippincott Co., 1988.
4. Harrap, K. R., Jackman, A. L., Newell, D. R., Taylor, G. A., Hughes, L. R., and Calvert, A. H. Thymidylate synthase: a target for anticancer drug design. Adv. Enzyme Regul., 29: 161-179, 1989.
5. Johnson, L. F. Post transcriptional regulation of thymidylate synthase gene expression. J. Cell. Biochem., 54: 378-392, 1994.
6. Keyomarsi, K., Samet, J., Molnar, G., and Pardee, A. B. The thymidylate synthase inhibitor ICI D 1694 overcomes translational detainment of the enzyme. J. Biol. Chem., 268: 15132-15149, 1993.
7. Chu. E., Koeller, D. M., Casey, J. L., Drake, J. C., Chabner, B. A., Elwood, P. C., Zinn, S., and Allegra, C. J. Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase. Proc. Natl. Acad. Sci. USA, 88: 8977-8981, 1991.
8. Chu. E., Voeller, D., Koeller, D. M., Drake, J., Takimoto, C. H., Maley, G. F., Maley, F., and Allegra, C. J. Identification of an RNA binding site for human thymidylate synthase. Proc. Natl. Acad. Sci. USA, 90: 517-521, 1993.
9. Chu, E., Cogliati, T., Copur, S. M., Borre, A., Voeller, D. M., Allegra, C. J., and Segal, S. Identification of in vivo target RNA sequences bound by thymidylate synthase. Nucleic Acids Res., 24: 3222-3228, 1996.
10. Dolnick, B. J. Cloning and characterization of a naturally occurring antisense RNA to human thymidylate synthase mRNA. Nucleic Acids Res., 21: 1747-1752, 1993.
11. Black, A. R., and Dolnick, B. J. Expression of rTS correlates with altered growth regulation of thymidylate synthase. Cancer Res., 56: 700-705, 1996.
12. Berger, S. H., and Berger, F. G. Thymidylate synthase as a determinant of 5-fluoro-2′-deoxyuridine response in human colonic tumor cell lines. Mol. Pharmacol., 34: 474-479, 1988.
13. Chu, E., and Allegra, C. J. Mechanisms of clinical resistance to 5-fluorouracil chemotherapy. Cancer Treat. Res., 87: 175-195, 1995.
14. Van der Wilt, C. L., Pinedo, H. M., Smid, K., and Peters, G. J. Elevation of thymidylate synthase following 5-fluorouracil treatment is prevented by the addition of leucovorin in murine colon tumors. Cancer Res., 52: 4922-4928, 1992.
15. Johnston, P. G., Lenz, H-J., Leichman, C. G., Danenberg, K. D., Allegra, C. J., Danenberg, P. V., and Leichman, L. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res., 55: 1407-1412, 1995.
16. Johnston, P. G., Fisher, E. R., Rockette, H. E., Fisher, B., Wolmark, N., Drake, J. C., Chabner, B. A., and Allegra, C. J. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J. Clin. Oncol., 12: 2640-2647, 1994.
17. Laemmli, U. K. Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680, 1970.
18. Gazit, G., Kane, S. E., Nichols, P., and Lee, A. S. Use of the stress-inducible grp78/BiP promoter in targeting high level gene expression in fibrosarcoma in vivo. Cancer Res., 55: 1660-1663, 1995.
19. Gorman, C., Padmanabhan, R., and Howard, B. H. High efficiency DNA-mediated transformation of primate cells. Science (Washington DC), 227: 551, 1983.
20. Keyomarsi, K., and Moran, R. G. Quinazoline folate analogs inhibit the catalytic activity of thymidylate synthase but allow the binding of 5-fluorodeoxyuridylate. J. Biol. Chem., 265: 19163-19169, 1990.
21. 2+-ATPase inhibitor thapsigargin. J. Biol. Chem., 268: 12003-12009, 1993.
22. Horikoshi, T., Danenberg, K. D., Stadlbauer, T. H. W., Volkenandt, M., Shea, L. C. C., Aigner, K., Gustavsson, B., Leichman, L., Frosing, R., Ray, M., Gibson, N. W., Spears, C. P., and Danenberg, P. V. Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using a polymerase chain reaction. Cancer Res., 52: 108-116, 1992.
23. Corrias, M. V., and Tonini, G. P. An oligomer complementary to the 5′ end region of MDR1 gene decrease resistance to doxorubicin of human adenocarcinoma-resistant cells. Anticancer Res., 12: 1431-1438, 1992.